Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 15621883869 |
E-mail: | liutf@jewim.com.cn |
QQ: | 172688504 |
Skype: | Chat Now! |
Address: | West Peitianmen Street,Taian High-Tech Industrial Development Zone, Shandong Province, China, |
Jewim Pharmaceutical (Shandong) Co., Ltd. was founded in Dec 1993. It is located at the foot of the world famous Mountain Tai in Shandong Province,China.
It has an aerosol&spray production center that can produce 55 million tubes of medical aerosols in No.49 Chuangye Street, East District, Tai’an Hi-Tech Industrial Development Zone. It has four automatic medical aerosol production lines imported from Switzerland and automatic nasal spray production lines. It is the largest MDIs manufacturer&exporter in China.In June 2013, aerosol & spray passed the GMP certification of Australian TGA.
It also has another factory area of 138,000m2 at Peitianmen Street, South District, Tai’an Hi-Tech Industrial Development Zone, with chemical raw material synthesis workshops, solid preparations (tablets, capsules, granules) workshop,DPIs(capsules&device,the fill machine imported from Germany) workshop,liquid preparations (nebules, sprays,enema etc.) workshop, semi-solid preparations (ointments, creams, gels) workshop.
Formed a strategic partnership with Johnson &johnson, as its well-known trademark “Daktarin" brand of authorized manufacturer, Our cGMP&EHS systems have been getting J &J’s support and recognition.
Our Misson:We are devoted to maintaining the health of all human beings and creating a Jewim brand with products having distinctive characteristics.
Our Core values: Sincere, Devoted, Esptit de Corps,Creative.
Our Quality Policy: To achieve customer satisfaction by consistently meeting regulatory and customer requirements. To provide consistent and sustainable production of safe and effective medicines by consistently improve the QMS.
|
Product Name | MF | CAS | Details |
---|
4-(3-fluoro-benzyloxy)-benzaldehyde | C14H11FO2 | 66742-57-2 | Details |
4-phenylthiobenzyl alcohol | C13H12OS | 6317-56-2 | Details |
1-Methylpyrrolidin-3-one | C5H9NO | 68165-06-0 | Details |
Tosufloxacin toluene sulfonate | C26H23F3N4O6S | 115964-29-9 | Details |
Lenvatinib | C21H19ClN4O4 | 417716-92-8 | Details |
2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-, (5R)- | C13H15NO4 | 452339-73-0 | Details |
4-chloro-7-methoxyquinoline-6-carboxamide | C11H9ClN2O2 | 417721-36-9 | Details |
5-(2,5-difluorophenyl)-3,4-dihydro-2H-pyrrole | C10H9F2N | 1443623-92-4 | Details |
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan | C17H16ClIO2 | 915095-94-2 | Details |
4-Amino-3-chlorophenol | C6H6ClNO | 17609-80-2 | Details |
4-(2-(tert-butylcarbonyl) formylhydrazyl) pyridine -N- oxide | C11H15N3O4 | 577778-86-0 | Details |
phenyl (R)-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)carbamate | C23H19F2N5O2 | 2135871-21-3 | Details |
BOC-ARGININE(NO2)-OH | C11H21N5O6 | 2188-18-3 | Details |
alpha-Cyclopentylmandelic acid | C13H16O3 | 427-49-6 | Details |
Parecoxib Sodium | C19H19N2NaO4S | 198470-85-8 | Details |
2-ethoxybenzaldehyde | C9H10O2 | 613-69-4 | Details |
N-Benzyl-(3S)-hydroxysuccinimide | C11H11NO3 | 101469-91-4 | Details |
Mirabellon | C21H24N4O2S | 223673-61-8 | Details |
8-Bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione | C10H9BrN4O2 | 666816-98-4 | Details |
Vilanterol | C24H33Cl2NO5 | 503068-34-6 | Details |
5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine | C6H3ClN4O2 | 1363380-51-1 | Details |
2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile | C13H9ClFN3O2 | 865759-24-6 | Details |
CarbaMic acid, [(2R)-2-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl]-, 1,1-diMethylethyl ester | C17H25NO5 | 452339-72-9 | Details |
Carbamic acid,N-[2-[4-hydroxy-3-(hydroxymethyl)phenyl]-2-oxoethyl]-,1,1,-dimethylethyl ester | C14H19NO5 | 1942890-99-4 | Details |
1,4-Dichlorophthalazine | C8H4Cl2N2 | 4752-10-7 | Details |
Pyrrolidine, 2-(2,5-difluorophenyl)-1-[(S)-(1,1-dimethylethyl)sulfinyl]-, (2R)- | C14H19F2NOS | 1443538-31-5 | Details |
4-phenylthiobenzaldehyde | C13H10OS | 1208-88-4 | Details |
Desonide | C24H32O6 | 638-94-8 | Details |
2-Propanesulfinamide, N-[4-chloro-1-(2,5-difluorophenyl)butylidene]-2-methyl-, [S(S)]- | C14H18ClF2NOS | 2227089-41-8 | Details |
Methyl 2-cyanoiso-nicotinate | C8H6N2O2 | 94413-64-6 | Details |
7-METHOXY-1-METHYL-2-TETRALONE | C12H14O2 | 1204-23-5 | Details |
2-(Bromomethyl)benzonitrile | C8H6BrN | 22115-41-9 | Details |
Vilanterol trifenatate | C44H49Cl2NO7 | 503070-58-4 | Details |
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | C18H42O6Si4 | 32384-65-9 | Details |
Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl) Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate | C30H36N8O4 | 668273-75-4 | Details |
CarbaMic acid, [2-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethyl]-, 1,1-diMethylethyl ester | C17H23NO5 | 452339-71-8 | Details |
(2R)-2-(2,5-difluorophenyl)-1-{pyrazolo[1,5-a]pyrimidin-5-yl}pyrrolidine | C16H14F2N4 | 1223404-89-4 | Details |
(S)-1-Benzyl-3-pyrrolidinol | C11H15NO | 101385-90-4 | Details |
Chlorohexadecane | C16H33Cl | 4860-03-1 | Details |
N-(tert-Butoxycarbonyl)-(S)-(+)-3-pyrrolidinol | C9H17NO3 | 101469-92-5 | Details |
5-Hydroxypyrazolo[1,5-a]pyrimidine | C6H5N3O | 29274-22-4 | Details |
2-(2,5-DIFLUORO-PHENYL)-PYRROLIDINE, HYDROCHLORIDE | C10H12ClF2N | 1197238-95-1 | Details |
4-Chloro-N-Methoxy-N-MethylbutyraMide | C6H12ClNO2 | 64214-66-0 | Details |
(S)-3-Hydroxypyrrolidine hydrochloride | C4H10ClNO | 122536-94-1 | Details |
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine | C16H15F2N5 | 1223404-88-3 | Details |
3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one | C6H4N4O3 | 1919868-75-9 | Details |
2-ethoxy benzoyl chloride | C9H9ClO2 | 42926-52-3 | Details |
5-Bromoacetyl-2-hydroxybenzaldehyde | C9H7BrO3 | 115787-50-3 | Details |
5,6-Dichloronicotinic acid | C6H3Cl2NO2 | 41667-95-2 | Details |
Regofini | C21H16Cl2F4N4O3 | 835621-07-3 | Details |
1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | C15H19N3O2 | 1267610-26-3 | Details |
(1R)-2-[[6-[2-[(2,6-Dichlorobenzyl)oxy]ethoxy]hexyl]aMino]-1-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)ethanol | C27H37Cl2NO5 | 503068-37-9 | Details |
4-Chloro-1-(2,5-difluorophenyl)butan-1-one | C10H9ClF2O | 1216260-42-2 | Details |
3, 4-dihydro-2h-pyrro-5-amine hydrochloride | C4H9ClN2 | 7544-75-4 | Details |
Alogliptin benzoate | C25H27N5O4 | 850649-62-6 | Details |
Naconazole hydrochloride | C17H22N2OS | 130726-68-0 | Details |
5-Chloropyrazolo[1,5-a]pyrimidine | C6H4ClN3 | 29274-24-6 | Details |
2-BROMO-1-[4-HYDROXY-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE | C9H9BrO3 | 62932-94-9 | Details |
1- (3,4-dimethylphenyl) - 3-methyl-1h-pyrazole-5 (4h) one | C12H14N2O | 18048-64-1 | Details |
5-Chloro-2-nitrodiphenylamine | C12H9ClN2O2 | 25781-92-4 | Details |
Besifloxacin Hydrochloride | C19H22Cl2FN3O3 | 405165-61-9 | Details |
3-(4-Morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1H)-pyridinone | C15H17N3O4 | 503615-03-0 | Details |
3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one | C20H25N3O3 | 545445-44-1 | Details |
Benzene, 2-[[2-[(6-broMohexyl)oxy]ethoxy]Methyl]-1,3-dichloro | C15H21BrCl2O2 | 503070-57-3 | Details |
Votexetine | C18H22N2S | 508233-74-7 | Details |
Bosutinib monohydrate | C26H31Cl2N5O4 | 918639-08-4 | Details |
3-Methyl-8-quinolinesulphonyl chloride | C10H8ClNO2S | 74863-82-4 | Details |
Bosutinib | C26H29Cl2N5O3 | 380843-75-4 | Details |
Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate | C9H17NO2 | 74892-82-3 | Details |
N-phenoxycarbonyl piperazine | C11H14N2O2 | 50606-33-2 | Details |
(S)-(+)-2-[4-(3-Fluorobenzyloxy)benzylamino]propanamice methansulfonate | C17H19FN2O2 | 133865-89-1 | Details |
Esomeprazole sodium | C34H36MgN6O6S2 | 161796-78-7 | Details |
Eltrombopag | C25H22N4O4 | 496775-61-2 | Details |
3 '- amino-2' - hydroxy - [1,1 '- biphenyl] - 3-carboxylic acid | C13H11NO3 | 376592-93-7 | Details |
Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | C20H17BrN6O2 | 853029-57-9 | Details |
Ethanol, 2-[(2,6-dichlorophenyl)Methoxy]- | C9H10Cl2O2 | 85309-91-7 | Details |
Phenyl hydrogen [(R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate | C15H18N5O4P | 379270-35-6 | Details |
Glycopyrronium Bromide | C19H28BrNO3- | 596-51-0 | Details |
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine | C16H13F2N5O2 | 1223404-90-7 | Details |
Cetylpyridine chloride | C21H40ClNO | 6004-24-6 | Details |
6α,9α- Difluoro-11 β- Hydroxy-16 α- Methyl-3-oxo-17 α- (1-propionyl) androsterol-1,4-diene-17 β- formic acid | C24H30F2O6 | 65429-42-7 | Details |
Bilastin | C28H37N3O3 | 202189-78-4 | Details |
1-Cbz-4-methylene-piperidine | C14H17NO2 | 138163-12-9 | Details |
1-methyl-3-pyrrolidol | C5H11NO | 99445-21-3 | Details |
N-[2-hydroxy-5-[(1RS) - 1-hydroxy-2-[[(1RS) - 2 - (4-methoxyphenyl) - 1-methylethyl] amino] ethyl] phenyl] formamide | C19H24N2O4 | 67346-49-0 | Details |
4-Amino-3-chlorophenol Hcl | C6H7Cl2NO | 52671-64-4 | Details |
2-Oxazolidinone, 3-[6-[2-[(2,6-dichlorophenyl)Methoxy]ethoxy]hexyl]-5-(2,2-diMethyl-4H-1, 3-benzodioxin-6-yl)-, (5R)- | C28H35Cl2NO6 | 503068-36-8 | Details |
(2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE | C10H11F2N | 1218935-59-1 | Details |
2-ethoxybenzoic acid | C9H10O3 | 134-11-2 | Details |
2-Cyano-5-fluorobenzyl bromide | C8H5BrFN | 421552-12-7 | Details |
1-Benzyl-3-pyrrolidinone | C11H13NO | 775-16-6 | Details |
(S)-3-Hydroxypyrrolidine hydrochloride | C4H9NO | 100243-39-8 | Details |
2,6-Dichlorobenzyl chloride | C7H5Cl3 | 2014-83-7 | Details |
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester | C11H13ClN2O3 | 27143-07-3 | Details |
Safinamide Mesylate | C17H19FN2O2.CH4O3S | 202825-46-5 | Details |
N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester | C21H29N6O5P | 379270-37-8 | Details |
Ethanone,2-amino-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-hydrochloride(1:1) | C9H11NO3 | 1044764-21-7 | Details |
2-Phenylacetophenone | C14H12O | 451-40-1 | Details |
Naphthalimostat methanesulfonate | C21H25N5O8S2 | 82956-11-4 | Details |
Product Total: Product Page: | ||||
1 2 3 |